Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Weekend reading: The mystery of some innovations that are slow to be accepted; myths about the obesity crisis

Weekend reading: The mystery of some innovations that are slow to be accepted; myths about the obesity crisis

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Combination therapy during cardiac arrest results in improved hospital discharge and neurological status

Combination therapy during cardiac arrest results in improved hospital discharge and neurological status

Low vitamin D blood levels associated with greater risk of heart disease varies by race, ethnicity

Low vitamin D blood levels associated with greater risk of heart disease varies by race, ethnicity

Quality of CPR may vary depending on EMS department or hospital administering it

Quality of CPR may vary depending on EMS department or hospital administering it

New research proves value of PET/MR compared to PET/CT in cardiac applications

New research proves value of PET/MR compared to PET/CT in cardiac applications

ZOLL Autopulse improves ROSC after sudden cardiac arrest

ZOLL Autopulse improves ROSC after sudden cardiac arrest

Experts call for international consensus on criteria used to diagnose circulatory and neurological death

Experts call for international consensus on criteria used to diagnose circulatory and neurological death

Four lifestyle behaviors protect against coronary heart disease, say researchers

Four lifestyle behaviors protect against coronary heart disease, say researchers

Experts to discuss on resuscitation efforts at Euroanaesthesia

Experts to discuss on resuscitation efforts at Euroanaesthesia

Bochum's medics use autologous cord blood to treat infantile cerebral palsy

Bochum's medics use autologous cord blood to treat infantile cerebral palsy

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

The Immortality Project awards $2.3M to study near-death experiences, beliefs in afterlife

The Immortality Project awards $2.3M to study near-death experiences, beliefs in afterlife

Study: Delayed transfer of patients to ICU increases risk of death in hospital

Study: Delayed transfer of patients to ICU increases risk of death in hospital

Hospitals that prevent cardiac arrests also have higher survival rates for cardiac arrest cases: Study

Hospitals that prevent cardiac arrests also have higher survival rates for cardiac arrest cases: Study

ECMO may show promise as rescue strategy for select cardiac arrest patients

ECMO may show promise as rescue strategy for select cardiac arrest patients

Researchers create first US map that pinpoints hotspots for infection and sepsis related-deaths

Researchers create first US map that pinpoints hotspots for infection and sepsis related-deaths

New nimodipine oral solution receives FDA approval for subarachnoid hemorrhage treatment

New nimodipine oral solution receives FDA approval for subarachnoid hemorrhage treatment

Gene offers new insights into treatment strategies for deep-vein thrombosis

Gene offers new insights into treatment strategies for deep-vein thrombosis

Heart Rhythm Society launches Citywide Awareness Campaign in Denver about cardiac arrhythmia

Heart Rhythm Society launches Citywide Awareness Campaign in Denver about cardiac arrhythmia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.